Expanded Newborn Screening in the Philippines 2026: All 28 Conditions Explained
Quick Answer: Expanded Newborn Screening (ENBS) is a heel-prick blood test that checks a Filipino baby for 28 congenital and metabolic conditions, up from the original 6-condition basic panel under Republic Act 9288. It's done ideally 24 hours after birth (never before), with results in 7–14 working days. PhilHealth covers the fee through the Newborn Care Package at PhilHealth-accredited facilities — see our newborn screening cost guide for the current peso breakdown. A positive result means confirmatory testing, not a diagnosis.
Table of Contents
- What is expanded newborn screening?
- Basic 6 vs. expanded 28: what changed?
- What are the 28 conditions, and why does each matter?
- When is newborn screening done?
- How much does it cost, and does PhilHealth cover it?
- What does a positive result mean?
- Where is newborn screening done?
- Frequently Asked Questions
- Conclusion
What is expanded newborn screening?
Expanded Newborn Screening (ENBS) is a blood test, taken from a few drops on a baby's heel, that screens for congenital metabolic, hormonal, and blood disorders before symptoms appear. It exists because Republic Act 9288, the Newborn Screening Act of 2004, made screening a standard part of newborn care in the Philippines, with the Department of Health (DOH) and the National Institutes of Health–Newborn Screening Reference Center (NIH-NSRC) at the University of the Philippines Manila running the system as RA 9288's designated technical partner.
Most of these conditions share a dangerous pattern: babies look completely healthy at birth, show no symptoms for weeks or months, and then suffer irreversible brain damage, disability, or death once the condition finally announces itself — by which point treatment is far less effective. Caught within the first days or weeks of life, most of these same conditions are manageable through diet, medication, or hormone replacement. That narrow window is the entire reason the test exists. Full program details are published by the Newborn Screening Reference Center.
Basic 6 vs. expanded 28: what changed?
The original NBS panel under RA 9288 covered 6 conditions. In 2014, DOH Administrative Order No. 2014-0045 (later amended by AO 2014-0045-A) expanded that panel to more than 28 disorders, using tandem mass spectrometry technology that can screen for dozens of metabolic markers from a single blood spot instead of testing for each condition separately.
| Basic NBS | Expanded NBS (ENBS) | |
|---|---|---|
| Conditions screened | 6 | 28 |
| Technology | Individual assays | Tandem mass spectrometry (MS/MS) |
| Legal basis | RA 9288 (2004) | DOH AO 2014-0045 / 2014-0045-A |
| Availability today | Being phased out at most facilities | Standard at most PhilHealth-accredited birthing facilities |
The basic 6 — congenital hypothyroidism (CH), congenital adrenal hyperplasia (CAH), galactosemia (GAL), phenylketonuria (PKU), G6PD deficiency, and maple syrup urine disease (MSUD) — are automatically included in the expanded 28. If your hospital offers ENBS, there's no separate decision to make about the basic 6; you're covered for those plus the 22 additional conditions below.
What are the 28 conditions, and why does each matter?
The 28-condition ENBS panel groups disorders by how the body fails to process a specific nutrient, hormone, or blood component. The table below groups them by category, based on DOH AO 2014-0045's disorder categories and the NIH-NSRC's public materials. Because Philippine hemoglobinopathy screening reports on a range of hemoglobin variants common in the local population (not a single fixed pair of conditions), treat that row as representative rather than exhaustive — newbornscreening.ph is the authoritative source if you need the exact current panel for a specific lab.
| Category | Conditions | Why it matters |
|---|---|---|
| Endocrine/hormonal | Congenital Hypothyroidism (CH), Congenital Adrenal Hyperplasia (CAH) | Untreated CH causes intellectual disability; untreated CAH can cause a life-threatening salt-wasting crisis in the first weeks of life |
| Carbohydrate metabolism | Galactosemia (GAL) | Baby cannot process galactose in milk; can cause liver failure and death if not switched off lactose immediately |
| Amino acid disorders | Phenylketonuria (PKU), Maple Syrup Urine Disease (MSUD), Homocystinuria (HCY), Citrullinemia (CIT), Tyrosinemia (TYR), Argininosuccinic aciduria (ASA) | Toxic buildup of amino acids damages the brain; managed through a strict special diet |
| Enzyme deficiency | Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency | Common in Filipino boys; triggers severe anemia from certain foods, drugs, or infections — avoidable once known |
| Fatty acid oxidation disorders | MCAD, LCHAD, VLCAD, trifunctional protein deficiency (TFP), carnitine uptake defect (CUD) | Baby can't convert fat to energy during fasting; risk of sudden, severe hypoglycemia — a preventable cause of unexplained infant death |
| Organic acid disorders | Isovaleric acidemia, glutaric acidemia type I, 3-MCC deficiency, methylmalonic acidemia, propionic acidemia, beta-ketothiolase deficiency, HMG-CoA lyase deficiency | Toxic acid buildup from incomplete protein/fat breakdown; causes metabolic crises requiring urgent dietary and medical management |
| Urea cycle disorders | Carbamoyl phosphate synthetase (CPS) deficiency, Ornithine transcarbamylase (OTC) deficiency | Body can't clear ammonia from protein breakdown; untreated buildup is neurotoxic |
| Hemoglobinopathies | Sickle cell disease, thalassemias, and other clinically significant hemoglobin variants | Abnormal red blood cells cause chronic anemia and complications; early diagnosis enables monitoring before symptoms hit |
| Other | Biotinidase deficiency, Cystic fibrosis (at facilities that include it) | Biotinidase deficiency is corrected with a daily vitamin; cystic fibrosis affects lungs and digestion and benefits from early nutritional support |
Every condition on this list is rare individually — most affect a small fraction of births — but collectively, the panel catches enough cases each year that DOH and NIH have built a nationwide referral network specifically to manage confirmed patients long-term (more on that below).
When is newborn screening done?
ENBS is ideally done starting 24 hours after birth, not before — testing too early can produce inaccurate results because certain metabolic markers haven't yet stabilized in the baby's blood. Most birthing facilities collect the sample before discharge, typically within the first one to three days of life. The Newborn Screening Reference Center states that normal ENBS results are available within 7–14 working days; abnormal or borderline results are flagged and communicated to the family much faster, often within a day or two of detection.
Premature or low-birth-weight babies are a documented exception: because their metabolism and enzyme levels may not be fully developed at 24 hours, they typically require a second screening around day 28 of life to catch conditions the first test could miss. If your baby was born early or small, ask your pediatrician whether a repeat test is needed — don't assume the first result is final.
How much does it cost, and does PhilHealth cover it?
ENBS is billed as part of PhilHealth's Newborn Care Package (NCP), a bundled benefit for newborns delivered at PhilHealth-accredited facilities that also covers Vitamin K, eye prophylaxis, hepatitis B and BCG vaccination, and newborn hearing screening. For a PhilHealth-accredited delivery, the ENBS fee is deducted directly from the package — most parents don't pay for it separately at the point of care.
We're intentionally not restating a specific peso figure for the NCP here: the officially cited amount has moved over the years (it stood at ₱2,950 following a 2019 enhancement), and multiple 2026 sources report a further increase tied to PhilHealth's broader 2026 maternity-benefit expansion — but as of this writing we could not confirm a single updated figure directly from a published PhilHealth circular. For the current, verified peso breakdown of ENBS and basic NBS pricing (with and without PhilHealth), see our dedicated newborn screening cost guide. If you don't have active PhilHealth coverage, you'll pay the out-of-pocket rate listed there instead.
What does a positive result mean?
A positive or "out-of-range" ENBS result means your baby is at higher risk for a condition — it is not a diagnosis. Newborn screening tests are deliberately built to be sensitive: they're designed to flag every possible case, which also means some flagged babies turn out not to have the condition once confirmed.
- Recall notification. The Newborn Screening Center or your birthing facility contacts you directly, usually within a day or two of an abnormal result.
- Confirmatory testing. Your baby is referred to a specialist — often at a genetics/metabolic center such as the Institute of Human Genetics at UP-PGH, a G6PD confirmatory center, or a hemoglobinopathy/metabolic reference laboratory — for a second, more specific test that confirms or rules out the condition.
- Continuity clinic referral. If confirmed, your baby is linked to one of the DOH's Newborn Screening Continuity Clinics for long-term follow-up, treatment, and monitoring. Babies confirmed with a rare disease are also covered under Republic Act 10747 (the Rare Diseases Act of the Philippines), which formally routes them into this same continuity-clinic and referral system, including telegenetics support for families in remote areas.
- Treatment starts immediately. Depending on the condition, this means lifelong hormone replacement (CH, CAH), a restricted diet (PKU, MSUD, organic acid disorders), a daily vitamin (biotinidase deficiency), or trigger avoidance (G6PD deficiency).
Don't panic on a positive screen, but don't delay the confirmatory appointment either — the entire value of ENBS depends on acting inside that early treatment window.
Where is newborn screening done?
Blood samples are collected at the hospital, lying-in clinic, birthing center, or rural health unit where your baby is born, then sent to one of the country's Newborn Screening Centers for laboratory analysis. If you gave birth at home or at a facility that didn't offer screening, you can still have it done at a nearby hospital, RHU, or pediatric clinic within the first week of life. Search for pediatric clinics and PhilHealth-accredited birthing facilities near you on ClinicFinderPH.
Frequently Asked Questions
How many conditions does expanded newborn screening test for?
28, up from the original 6-condition basic panel under RA 9288. The expansion took effect under DOH Administrative Order No. 2014-0045 in 2014, using tandem mass spectrometry to screen for endocrine, metabolic, enzyme, and blood disorders from a single heel-prick blood sample.
What is the difference between basic and expanded newborn screening?
Basic NBS tests for 6 conditions: congenital hypothyroidism, congenital adrenal hyperplasia, galactosemia, phenylketonuria, G6PD deficiency, and maple syrup urine disease. Expanded NBS (ENBS) includes all 6 of those plus 22 additional amino acid, fatty acid oxidation, organic acid, urea cycle, hemoglobin, and other disorders, for 28 total. ENBS is now the standard offering at most PhilHealth-accredited facilities.
When should my baby be screened?
Ideally starting 24 hours after birth — testing earlier can give inaccurate results. Most hospitals collect the sample before discharge, within the first one to three days of life. Premature or low-birth-weight babies typically need a second screening around day 28.
Magkano ang expanded newborn screening sa Philippines?
It's billed through PhilHealth's Newborn Care Package for PhilHealth-accredited deliveries, so most parents pay nothing extra at the point of care. The exact peso amount PhilHealth currently covers has changed over the years and wasn't fully confirmed as of this writing — see our newborn screening cost guide for the current verified pricing, with and without PhilHealth.
What happens if the result is positive?
A positive result means your baby needs confirmatory testing — it does not mean your baby has the condition. You'll be contacted for a follow-up test at a specialist center, and if the condition is confirmed, your baby is referred to a DOH Newborn Screening Continuity Clinic for ongoing treatment and monitoring.
Is newborn screening required by law?
RA 9288 requires healthcare providers to offer and strongly encourage newborn screening for every baby born in the Philippines. Parents can decline, but the law is built around the assumption that screening happens — it's a core part of standard newborn care, not an optional add-on.
Can I still get my baby screened if I gave birth at home?
Yes. Bring your baby to a nearby hospital, rural health unit, or pediatric clinic within the first week of life to have the sample collected. Waiting too long past the first week reduces the accuracy and usefulness of the results.
Does ENBS replace newborn hearing screening?
No, they're separate tests bundled into the same PhilHealth Newborn Care Package. ENBS checks blood for metabolic, hormonal, and blood disorders; newborn hearing screening separately checks for congenital hearing loss using auditory equipment. Ask your facility to confirm both are done before discharge.
Conclusion
Expanded Newborn Screening exists because a handful of rare but serious conditions are only dangerous if they go undetected — catch them in the first days of life, and most are manageable for the long term. RA 9288 makes the offer standard at every birthing facility in the Philippines, and PhilHealth-accredited hospitals bill the fee through the Newborn Care Package rather than charging parents directly. For the exact current peso amounts, read our newborn screening cost guide. If you're also tracking the broader financial side of delivery, see our PhilHealth maternity benefits guide, the step-by-step PhilHealth maternity claim guide, and the 2026 PhilHealth maternity benefit increase. You can also search for pediatric clinics and PhilHealth-accredited birthing facilities near you on ClinicFinderPH.